DailyIQ
|
Sector:HealthcareAll sectors
Last updated 4 minutes ago

RVTY·Revvity, Inc.

$.
-. (-.%)
After Hours
High
$114.15
Open
$113.48
Market Cap
12.53B
52W High
$118.30
Low
$111.84
P. Close
$112.31
P/E
52.27
52W Low
$81.22
Fwd P/E
19.26
DailyIQ Est.
$117.48
Technical Score (1D)
91
BUY
News Sentiment
74
BULLISH
Anthropic has added Revvity Signals to its Model Context Protocol, allowing scientists to pull Revvity’s ontology‑driven data directly into Claude’s reasoning tools. This integration embeds Revvity’s data platform inside a leading generative‑AI workbench, potentially streamlining AI‑driven discovery workflows for life‑science researchers. By making its data more accessible through a popular AI interface, Revvity could attract a broader client base and accelerate adoption of its Signals software. The move also signals a shift toward higher‑margin software and AI‑enabled services, which may improve Revvity’s earnings profile over the next few quarters. For traders, the immediate implication is that any uptick in user activity or revenue from the new partnership could support a bullish valuation narrative. Watch for early adoption metrics released by Revvity, such as new user sign‑ups or usage volume on the Claude‑enabled platform, which will gauge the partnership’s traction. Additionally, monitor any product roadmap updates that might reveal further AI integrations or enhancements to the Signals platform. If Revvity can demonstrate rapid uptake, it may prompt a reevaluation of the company’s growth prospects by analysts. Conversely, a lack of measurable impact could temper enthusiasm and lead to a reassessment of the AI‑driven strategy.
Earnings Summary
Revvity, Inc. (RVTY) is a health science solutions provider that delivers instruments, reagents, software, and services for genetic testing and research, serving pharmaceutical companies, research institutions, and healthcare providers; its portfolio supports newborn screening, oncology research, and immunodiagnostics. In the most recent two quarters, Revvity posted EPS of $1.70 in Q4 2025 and $1.06 in Q1 2026, compared with $1.18 in both Q2 and Q3 2025, showing a sharp decline in earnings after a period of steady growth; revenue rose from $698.95 M in Q3 2025 to $772.06 M in Q4 2025 before falling to $711.12 M in Q1 2026, indicating a revenue peak followed by a contraction. Historically, Revvity has consistently outperformed analyst expectations, beating EPS estimates in five of the six quarters reported, with the sole miss occurring in Q1 2026; revenue growth has been robust through 2025, though the recent dip suggests a potential shift in demand or cost dynamics. Recent developments include Anthropic’s integration of Revvity Signals into its Claude model, positioning the company to offer AI‑enabled analytics and potentially broaden its client base; the partnership is expected to accelerate adoption of the Signals platform and could improve Revvity’s earnings profile if uptake is strong. Investors should watch for early adoption metrics and usage volume on the Claude‑enabled platform, as well as any updates on product roadmap enhancements, to gauge the partnership’s impact; additionally, the upcoming earnings call on August 4 2026 will provide guidance on revenue, margins, and capital allocation, offering insight into whether the recent revenue contraction is temporary or indicative of a longer‑term trend.

EPS

EstBeatMiss
$0.84$1.08$1.32$1.57$1.81Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.22 - -
Q1'26$1.23$1.06-13.8%
Q4'25$1.58$1.70+7.5%
Q3'25$1.14$1.18+3.6%
Q2'25$1.14$1.18+3.4%
Q1'25$0.95$1.01+6.4%

Revenue

EstBeatMiss
$648M$684M$721M$757M$793MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$724M - -
Q1'26$736M$711M-3.4%
Q4'25$777M$772M-0.6%
Q3'25 - $699M -
Q2'25 - $720M -
Q1'25 - $665M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

RVTY Stock Snapshot

RVTY is currently trading at $112.18, giving Revvity, Inc. a market cap of 12.53B and a P/E ratio of 52.3. Today's range spans $111.84–$114.15, with shares opening at $113.48 and moving down $0.13 (0.1%) from the prior close. DailyIQ's technical score sits at 91/100 (BUY) with a news sentiment reading of 74/100.

Over the past year RVTY has traded between $81.22 and $118.30 - the current price is +38.1% off the 52-week low and -5.2% from the high. 27 analysts cover the stock with a Hold consensus and a mean 12-month target of $114.73 (range $90.00–$145.00), implying upside of +2.3%.

Revvity, Inc. (RVTY) is a large-cap in Healthcare with 12.53B in market cap, and the current setup is one of the cleaner bullish reads in the space. Technical score: 91/100 (BUY). Sentiment: bullish at 74/100. Price: $112.18 (in the upper portion of its 52-week range). The current P/E ratio stands at 52.3. The 52-week range of $81.22–$118.30 provides structural context - and the current technical/sentiment alignment is the type of setup that attracts both momentum and growth-oriented capital.

The combination of a BUY signal (91/100) and bullish news sentiment (74/100) puts RVTY on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 12.53B in Healthcare market cap without immediately moving the stock. At $112.18 (in the upper portion of its 52-week range in the $81.22–$118.30 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.